Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 10, 2014 - Issue
Submit an article Journal homepage
102
Views
10
CrossRef citations to date
0
Altmetric
Case Report

Schizophrenia relapse after stopping olanzapine treatment during pregnancy: a case report

Petru Ifteni1 Faculty of Medicine, Transilvania University, Brasov, Romania;2 Psychiatry and Neurology Hospital, Brasov, RomaniaCorrespondence[email protected]
,
Marius A Moga1 Faculty of Medicine, Transilvania University, Brasov, Romania
,
Victoria Burtea1 Faculty of Medicine, Transilvania University, Brasov, Romania;2 Psychiatry and Neurology Hospital, Brasov, Romania
&
Christoph U Correll3 Department of Psychiatry, The Zucker Hillside Hospital, North Shore-Long Island Jewish (LIJ) Health System, New York, NY, USA;4 Hofstra North Shore-LIJ School of Medicine, New York, NY, USA
Pages 901-904 | Published online: 23 Oct 2014

References

  • FreemanMPPregnancy and psychiatric disorders: inherent risks and treatment decisionsJ Clin Psychiatry201374437337423656843
  • BrunnerEFalkDMJonesMDeyDKShatapathyCCOlanzapine in pregnancy and breastfeeding: a review of data from global safety surveillanceBMC Pharmacol Toxicol2013143823902726
  • ReisMKällénBMaternal use of antipsychotics in early pregnancy and delivery outcomeJ Clin Psychopharmacol200828327928818480684
  • LinHCChenIJChenYHLeeHCWuFJMaternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference?Schizophr Res20101161556019896335
  • IqbalMMAnejaARahmanAThe potential risks of commonly prescribed antipsychotics: during pregnancy and lactationPsychiatry (Edgmont)200528364421152171
  • DefoortENKimPMWinnLMValproic acid increases conservative homologous recombination frequency and reactive oxygen species formation: a potential mechanism for valproic acid-induced neural tube defectsMol Pharmacol20066941304131016377765
  • ZipurskyRBMenezesNMSteinerDLRisk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic reviewSchizophr Research20141522–3408414
  • LeuchtSTardyMKomossaKAntipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysisLancet201237998312063207122560607
  • ACOG Committee on Practice Bulletins–ObstetricsACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactationObstet Gynecol200811141001102018378767
  • GoldsteinDJCorbinLAFungMCOlanzapine-exposed pregnancies and lactation: early experienceJ Clin Psychopharmacol200020439940310917399
  • BiswaslPNWiltonLVPearcelGLFreemantleSShakirSAThe pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8,858 patients in EnglandJ Psychopharmacol200115426527111769820
  • RoweMGowdaBATaylorDHannamSHowardLMNeonatal hypoglycaemia following maternal olanzapine therapy during pregnancy: a case reportTher Adv Psychopharmacol20122626526823983985
  • PrakashSChaddaRKTeratogenicity with olanzapineIndian J Psychol Med2014361919324701021
  • KirchheinerJBerghoferABolk-WeischedelDHealthy outcome under olanzapine treatment in a pregnant womanPharmacopsychiatry2000332788010761825

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.